Acute graft-versus-host disease: from the bench to the bedside

TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors

(2009) H. E. Kohrt et al.   BLOOD

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

(2009) A. M. Alousi et al.   BLOOD

Do studies in humans better depict Th17 cells?

(2009) F. Annunziato et al.   BLOOD

Programming Perpetual T Helper Cell Plasticity

(2009) Emily Rowell et al.   IMMUNITY

Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning

(2009) James L. Riley et al.   IMMUNITY

Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation

(2009) Muzlifah Haniffa et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET

Induction of natural killer T cell–dependent alloreactivity by administration of granulocyte colony–stimulating factor after bone marrow transplantation

(2009) Edward S Morris et al.   NATURE MEDICINE

Polymorphisms of cytokine and innate immunity genes and GVHD

(2008) A.M. Dickinson et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease

(2008) T. Hori et al.   BLOOD

HapMap scanning of novel human minor histocompatibility antigens

(2008) M. Kamei et al.   BLOOD

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival

(2008) S. W. Choi et al.   BLOOD

A biomarker panel for acute graft-versus-host disease

(2008) S. Paczesny et al.   BLOOD

Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease

(2008) T. Yi et al.   BLOOD

Outcome of alloanergized haploidentical bone marrow transplantation after ex vivo costimulatory blockade: results of 2 phase 1 studies

(2008) J. K. Davies et al.   BLOOD

IL-17 contributes to CD4-mediated graft-versus-host disease

(2008) L. W. Kappel et al.   BLOOD

In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations

(2008) M. J. Carlson et al.   BLOOD

CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease

(2008) Husein Hadeiba et al.   NATURE IMMUNOLOGY

Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality

(2007) L. K. Jasperson et al.   BLOOD